The Safety and Effectiveness of NV-A01 in Glioma Patients

NCT06193538 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Advanced Glioblastoma Patients

Interventions

DRUG: Recombinant NV-A01 adenovirus injection

Sponsor

First Affiliated Hospital of Wannan Medical College